ÁNGELA
GUTIÉRREZ CAMINO
Instituto de Investigación Sanitaria Biocruces Bizkaia
Barakaldo, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria Biocruces Bizkaia (23)
2023
-
The Role of the Dysregulation of Long Non-Coding and Circular RNA Expression in Medulloblastoma: A Systematic Review
Cancers, Vol. 15, Núm. 19
-
microRNA sequencing for biomarker detection in the diagnosis, classification and prognosis of Diffuse Large B Cell Lymphoma
Scientific reports, Vol. 13, Núm. 1, pp. 12159
2022
-
Diverse mutations and structural variations contribute to Notch signaling deregulation in paediatric T-cell lymphoblastic lymphoma
Pediatric Blood and Cancer, Vol. 69, Núm. 11
-
MicroRNA-based therapeutic strategies for cancer
MicroRNA: From Bench to Bedside (Elsevier), pp. 503-520
2021
-
Prognostic and therapeutic value of somatic mutations in diffuse large B-cell lymphoma: A systematic review
Critical Reviews in Oncology/Hematology, Vol. 165
2020
-
Role of rs10406069 in miR-5196 in hyperdiploid childhood acute lymphoblastic leukemia
Epigenomics, Vol. 12, Núm. 22, pp. 1949-1955
2019
-
MiRNA deregulation in childhood acute lymphoblastic leukemia: A systematic review
Epigenomics, Vol. 12, Núm. 1, pp. 69-80
-
Variants in vincristine pharmacodynamic genes involved in neurotoxicity at induction phase in the therapy of pediatric acute lymphoblastic leukemia
Pharmacogenomics Journal, Vol. 19, Núm. 6, pp. 564-569
2018
-
Involvement of SNPs in miR-3117 and miR-3689d2 in childhood acute lymphoblastic leukemia risk
Oncotarget, Vol. 9, Núm. 33, pp. 22907-22914
-
Involvement of miRNA polymorphism in mucositis development in childhood acute lymphoblastic leukemia treatment
Pharmacogenomics, Vol. 19, Núm. 18, pp. 1403-1412
-
Mir-pharmacogenetics of Vincristine and peripheral neurotoxicity in childhood B-cell acute lymphoblastic leukemia
Pharmacogenomics Journal, Vol. 18, Núm. 6, pp. 704-712
-
Pharmacoepigenetics in childhood acute lymphoblastic leukemia: Involvement of miRNA polymorphisms in hepatotoxicity
Epigenomics, Vol. 10, Núm. 4, pp. 409-417
-
Role of miRNAs in treatment response and toxicity of childhood acute lymphoblastic leukemia
Pharmacogenomics, Vol. 19, Núm. 4, pp. 361-373
-
Variants in the 14q32 miRNA cluster are associated with osteosarcoma risk in the Spanish population
Scientific Reports, Vol. 8, Núm. 1
2017
-
Confirmation of involvement of new variants at CDKN2A/B in pediatric acute lymphoblastic leukemia susceptibility in the Spanish population
PLoS ONE, Vol. 12, Núm. 5
-
Genetic susceptibility in childhood acute lymphoblastic leukemia
Medical Oncology, Vol. 34, Núm. 10
-
MTHFR polymorphisms in childhood acute lymphoblastic leukemia: Influence on methotrexate therapy
Pharmacogenomics and Personalized Medicine, Vol. 10, pp. 69-78
-
PNPLA3 rs738409 and Hepatotoxicity in Children With B-cell Acute Lymphoblastic Leukemia: A Validation Study in a Spanish Cohort
Clinical Pharmacology and Therapeutics
-
Review of pharmacogenetics studies of L-asparaginase hypersensitivity in acute lymphoblastic leukemia points to variants in the GRIA1 gene
Drug Metabolism and Personalized Therapy, Vol. 32, Núm. 1, pp. 1-9
2016
-
Lack of association of the CEP72 RS924607 TT genotype with vincristine-related peripheral neuropathy during the early phase of pediatric acute lymphoblastic leukemia treatment in a Spanish population
Pharmacogenetics and Genomics, Vol. 26, Núm. 2, pp. 100-102